Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Levine

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Annals of Surgery|June 30, 2018
A Roadmap for Aspiring Surgeon-Scientists in Today's Healthcare EnvironmentAllan M Goldstein, Alex B Blair, Sundeep G Keswani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 12, 2015
Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidatesPeter P Reese, Justine Shults, Roy D Bloom, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2024
Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasisKe-Bin Huang, Feng-Yang Wang, Yuan Lu, et al.
Transplantation|October 12, 2013
Functional status and survival after kidney transplantationPeter P Reese, Roy D Bloom, Justine Shults, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2021
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant RecipientsLauren N Krumeich, Jenna Mancinelli, Andy Cucchiara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trialsBernd Schröppel, Enver Akalin, Mukta Baweja, et al.
Transplantation Direct|April 27, 2026
Outcomes of Simultaneous Liver-Kidney Transplant and Kidney After Liver Transplant Using the Safety Net Criteria-A Single-center ExperienceSrijan Tandukar, Vishnu S Potluri, Peter Abt, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipientsRonald F Parsons, Arslan Zahid, Shalini Bumb, et al.
Kidney International Reports|July 13, 2023
Longer-Term Clinical Outcomes From the THINKER and EXPANDER Trials of Transplantation of HCV-RNA+ Donor Kidneys Into Hepatitis C Virus-Negative RecipientsVishnu Potluri, Fizza Naqvi, David S Goldberg, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Annals of Surgery|June 30, 2018
A Roadmap for Aspiring Surgeon-Scientists in Today's Healthcare EnvironmentAllan M Goldstein, Alex B Blair, Sundeep G Keswani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 12, 2015
Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidatesPeter P Reese, Justine Shults, Roy D Bloom, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2024
Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasisKe-Bin Huang, Feng-Yang Wang, Yuan Lu, et al.
Transplantation|October 12, 2013
Functional status and survival after kidney transplantationPeter P Reese, Roy D Bloom, Justine Shults, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2021
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant RecipientsLauren N Krumeich, Jenna Mancinelli, Andy Cucchiara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trialsBernd Schröppel, Enver Akalin, Mukta Baweja, et al.
Transplantation Direct|April 27, 2026
Outcomes of Simultaneous Liver-Kidney Transplant and Kidney After Liver Transplant Using the Safety Net Criteria-A Single-center ExperienceSrijan Tandukar, Vishnu S Potluri, Peter Abt, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipientsRonald F Parsons, Arslan Zahid, Shalini Bumb, et al.
Kidney International Reports|July 13, 2023
Longer-Term Clinical Outcomes From the THINKER and EXPANDER Trials of Transplantation of HCV-RNA+ Donor Kidneys Into Hepatitis C Virus-Negative RecipientsVishnu Potluri, Fizza Naqvi, David S Goldberg, et al.
Pageof 4